Priya Sachdeva
Stock Analyst at UBS
(3.68)
# 2,160
Out of 4,966 analysts
14
Total ratings
90%
Success rate
26.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Priya Sachdeva
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRC AtriCure | Rated: Buy | $50 | $54.54 | -8.32% | 1 | Jul 28, 2026 | |
| MDT Medtronic | Rated: Hold | $90 → $85 | $90.96 | -6.55% | 2 | Jun 4, 2026 | |
| PEN Penumbra | Downgraded: Hold | $335 → $374 | $317.75 | +17.70% | 7 | Jan 20, 2026 | |
| NPCE NeuroPace | Reiterated: Buy | $18 → $22 | $14.04 | +56.70% | 4 | Dec 16, 2025 |
AtriCure
Jul 28, 2026
Rated: Buy
Price Target: $50
Current: $54.54
Upside: -8.32%
Medtronic
Jun 4, 2026
Rated: Hold
Price Target: $90 → $85
Current: $90.96
Upside: -6.55%
Penumbra
Jan 20, 2026
Downgraded: Hold
Price Target: $335 → $374
Current: $317.75
Upside: +17.70%
NeuroPace
Dec 16, 2025
Reiterated: Buy
Price Target: $18 → $22
Current: $14.04
Upside: +56.70%